<p>This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs.</p>
申请公布号
WO2013063186(A2)
申请公布日期
2013.05.02
申请号
WO2012US61782
申请日期
2012.10.25
申请人
NOVARTIS ANIMAL HEALTH US, INC.
发明人
RUE, SARAH;ECKELMAN, BRENDAN;DEVERAUX, QUINN;NASOFF, MARC
